Form 8-K - Current report:
SEC Accession No. 0001104659-22-030903
Filing Date
2022-03-07
Accepted
2022-03-07 09:02:23
Documents
20
Period of Report
2022-03-03
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm228411d1_8k.htm   iXBRL 8-K 31454
2 EXHIBIT 4.1 tm228411d1_ex4-1.htm EX-4.1 90285
3 EXHIBIT 4.2 tm228411d1_ex4-2.htm EX-4.2 97064
4 EXHIBIT 5.1 tm228411d1_ex5-1.htm EX-5.1 10849
5 EXHIBIT 10.1 tm228411d1_ex10-1.htm EX-10.1 190589
6 EXHIBIT 99.1 tm228411d1_ex99-1.htm EX-99.1 12247
10 GRAPHIC tm228411d1_ex5-1img001.jpg GRAPHIC 1609
11 GRAPHIC tm228411d1_ex5-1img002.jpg GRAPHIC 17151
12 GRAPHIC image_001.jpg GRAPHIC 8672
  Complete submission text file 0001104659-22-030903.txt   750053

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA eyen-20220303.xsd EX-101.SCH 3042
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE eyen-20220303_lab.xml EX-101.LAB 34476
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eyen-20220303_pre.xml EX-101.PRE 22601
14 EXTRACTED XBRL INSTANCE DOCUMENT tm228411d1_8k_htm.xml XML 3702
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Filer) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38365 | Film No.: 22716461
SIC: 2834 Pharmaceutical Preparations